It is not a substitute for clinical care, but it can help reinforce the maintenance conversation and give patients something structured to use between appointments
Novo Nordisk asks FDA not to allow GLP-1 compounding Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs
Herein, we successfully switched a patient with acromegaly from a dipeptidyl peptidase-4 (DPP-4) inhibitor to a glucagon-like peptide-1 (GLP-1) analog due to pasireotide-induced deterioration of glycemic control, and we examined the underlying mechanism for glycemic control
Targets injury recovery through simultaneous angiogenesis promotion, fibroblast activation, and cellular migration cascades
PRP delivers concentrated growth factors derived from your own blood
What you get with Verge Personalized dosing and titration Online consults and provider review Ongoing check-ins and 24/7 messaging Direct-to-door shipping with all supplies included Clinical monitoring for safety and results 2